41.
Determinants of COVID-19 disease severity in patients with cancer
by Robilotti, Elizabeth V
Nature medicine, 2020-08, Vol.26 (8), p.1218-1223
42.
Immune determinants of COVID-19 disease presentation and severity
by Brodin, Petter
Nature medicine, 2021-01, Vol.27 (1), p.28-33
43.
Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
by Haroon, Muhammad
Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1045-1050
44.
Does atopic dermatitis cause food allergy? A systematic review
by Tsakok, Teresa, MRCP, MA
Journal of allergy and clinical immunology, 2016, Vol.137 (4), p.1071-1078
45.
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
by McInnes, Iain B, Prof
The Lancet (British edition), 2015, Vol.386 (9999), p.1137-1146
46.
Rituximab for IgG4-related disease: a prospective, open-label trial
by Carruthers, Mollie N
Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1171-1177
47.
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomi...
by Mohr, Friedrich W, Prof
The Lancet (British edition), 2013, Vol.381 (9867), p.629-638
48.
Insights into epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme
by Govetto, Andrea
American journal of ophthalmology, 2016, Vol.175, p.99-113
49.
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
by Landa, Iñigo
The journal of clinical endocrinology and metabolism, 2013-09, Vol.98 (9), p.E1562-E1566
50.
A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach
by Roberts, Helen C
Age and ageing, 2011-07, Vol.40 (4), p.423-429
51.
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
by Wilk, Aaron J
Nature medicine, 2020-07, Vol.26 (7), p.1070-1076
52.
Cellular immune correlates of protection against symptomatic pandemic influenza
by Sridhar, Saranya
Nature medicine, 2013-10, Vol.19 (10), p.1305-1312
53.
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
by Xing, Weijia, PhD
The Lancet infectious diseases, 2014, Vol.14 (4), p.308-318
54.
Definition and classification of cancer cachexia: an international consensus
by Fearon, Kenneth, Prof
The lancet oncology, 2011, Vol.12 (5), p.489-495
55.
Systemic lupus erythematosus
by Lisnevskaia, Larissa, MD
The Lancet (British edition), 2014, Vol.384 (9957), p.1878-1888
56.
Individualised exercise improves endothelial function in patients with rheumatoid arthritis
by Metsios, George S
Annals of the rheumatic diseases, 2014-04, Vol.73 (4), p.748-751
57.
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
by Bachert, Claus
Journal of allergy and clinical immunology, 2017-10, Vol.140 (4), p.1024-1031.e14
58.
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
by Iadecola, Costantino
Hypertension (Dallas, Tex. 1979), 2016-12, Vol.68 (6), p.e67-e94
59.
Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy
by Gomez-Arango, Luisa F
Hypertension (Dallas, Tex. 1979), 2016-10, Vol.68 (4), p.974-981
60.
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase...
by Feagan, Brian G, Prof
The Lancet (British edition), 2017, Vol.389 (10080), p.1699-1709
